New plan to nab illegals revealed

New plan to nab illegals revealed
Updated 20 April 2013

New plan to nab illegals revealed

New plan to nab illegals revealed
There will be three options under a new plan by the Ministry of Labor to obtain information on companies that are violating labor laws, said Adel Fakeih, minister of labor, yesterday on an MBC show hosted by Dawood Al-Shirian.
The first option is for the members of the public to report companies or individual violators by calling in the ministry through a toll free number. 
The second option is self-inspection whereby the business owner can find online whether their business is committing any violations. 
The third option is inspections carried out by the ministry itself.
He said that 100,000 new inspectors would join the ministry to help carry out the inspections. They will now be accompanied by police officers for effective implementation of the ministry’s directives. The new program begins next month.
The minister acknowledged the contribution of the expatiate community, but said that illegal activity will not be tolerated. “We enforce the rules and regulations on every establishment with no exceptions.” 
He said that about 900,000 workers have been deported in the last 18 months and that nearly 400,000 Saudis have been hired during the same  period. 
Fakeih said the purpose of Saudization should not be misunderstood and that expats who are legally allowed to work in the country have contributed to Saudi growth. He added that 7.5 million expats are currently legally working in the Kingdom.
Companies that employ illegals will be fined up to SR 100,000 and sentenced to two years in prison for each illegal worker they hire. 
The ministry will also accept tips from the general public if they see anyone working illegally.
He said that any expat who did not get his/her iqama renewed by the sponsor can choose any company in Nitaqat’s green zone and transfer the sponsorship to it without the permission of the former sponsor.
“The former sponsor loses his/her right to keep his workers if he/she fails to renew the iqama before its expiration date,” Adel said.
Fakeih clarified that children of Saudi mothers who are married to non-Saudis are considered Saudis under Nitaqat. 
 

 


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 16 January 2021

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.